All News

Commensal gut bacterium protects from severe intestinal infection

The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered.

VUMC scientists discover key step to kidney fibrosis

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure.

Neuroscientist Véronique Belzil, PhD, MS

Belzil to establish VUMC ALS Research Center

Neuroscientist Véronique Belzil, PhD, MS, will join Vanderbilt University Medical Center as associate professor of Neurology and director of ALS (amyotrophic lateral sclerosis) research.

T cells (orange) engage with cancer cells (blue). Halle Borowski, an artist and senior at the College of William and Mary, worked with Drs. Mary Philip and Jess Roetman to create this oil painting, inspired by their research, as part of the Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4) Artist-in-Residence program (https://www.artlab-air.com/).

Tumor antigens key to improving cancer immunotherapy: study

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.

Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute

Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), has been named director of the National Cancer Institute

Random acts of kindness and team building put pediatric nurse anesthetist Caroline Campbell in the spotlight with Credo Award

“When people are feeling down, I want to do something to make everyone feel better.”

1 92 93 94 95 96 144